Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
Emerging technologies in oncology care include specialized LLMs, AI-assisted CT scans for early detection, and foundational models that democratize pathology.
Read the original →Researchers developed a CNN-BiLSTM-Attention hybrid neural network optimized by an improved antlion algorithm. It diagnoses and predicts transformer faults with 98.28 percent accuracy.
Read the original →A new cardiac MRI and machine-learning study shows that layer-specific heart muscle strain combined with routine blood tests can distinguish acute myocarditis from heart attacks with strong accuracy.
Read the original →AI tools are streamlining retina practice. Adoption depends on fitting them into real-world workflows.
Read the original →A Medical Protection Society poll of nearly 160 practice managers finds AI-drafted patient complaints are long and legalistic. They are adding to pressure on GP teams.
Read the original →A scoping review found only three studies of artificial intelligence for assessing fever in returning travellers. All were promising in controlled settings but lacked external validation.
Read the original →Researchers in Shandong, China, developed and externally validated machine learning models that use preoperative data. The models predict complications, prolonged hospital stay, and postoperative pain.
Read the original →Tempus AI is expanding its presence in precision medicine through collaborations, which may support future revenue growth. It entered an expanded multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), an individualized therapy.
Read the original →Gix Internet's deliverz.ai subsidiary has expanded its autonomous hospital logistics operations to include critical medical specimens. This builds on an existing chemotherapy delivery programme and demonstrates additional applications for its Physical AI platform.
Read the original →Hospitals are looking for more efficient ways to manage disinfection. The co-founder is exploring how autonomous systems can bring physical AI into healthcare workflows.
Read the original →PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples. The data will be used to train AI models and accelerate the development of RNA therapies for rare diseases.
Read the original →The UBS CIO warns that AI could disrupt the digital economy. The note points to "atoms over bits," AI infrastructure ETF picks, and healthcare diversifiers for portfolios.
Read the original →AI, multicellular organoids, and high-content screening support triple-negative breast cancer drug discovery.
Read the original →Chai Discovery announced an expanded collaboration with GSK after a successful laboratory evaluation of its AI-powered molecular design technology. The agreement will provide GSK with access to Chai's technology.
Read the original →He predicted that AI would play a crucial role in medicine over the next decade. He said it could be a source of second opinions during treatment.
Read the original →A Lancet Commission has outlined 17 interconnected global threats that could cause catastrophic health losses by 2100. It says countries including India must treat these risks as linked economic, environmental and security challenges.
Read the original →Chinese artificial intelligence applications are speeding their expansion into ASEAN markets. Breakthroughs are emerging in smart agriculture and cross-border medical education.
Read the original →A finance company employee in Shanghai, Wang Lu, says she photographs her meals before eating. She spends a few minutes each day using an AI tool before meals.
Read the original →The DeepGEM 2.0 model can also run preliminary screening for gene targets corresponding to lung cancer targeted therapies already approved in China.
Read the original →PeopleX announced on October 7, 2026 that its service, scheduled for release in November, will show AI skills on a 10-level scale. It will also extend its support to cyber training.
Read the original →